Similar articles

• Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.

  Salvesen C, Vaksdal K. Salvesen C, et al. Behav Neuropsychiatry. 1973 Oct-1974 Mar;5(7-12):3-7. Behav Neuropsychiatry. 1973. PMID: 4154740 No abstract available.
• A long-term pilot study of pipothiazine palmitate in chronic schizophrenia.

  Villeneuve A, Pires A, Jus A, Lachance R, Drolet A. Villeneuve A, et al. Curr Ther Res Clin Exp. 1972 Nov;14(11):696-706. Curr Ther Res Clin Exp. 1972. PMID: 4404626 No abstract available.
• [Comparative study of delayed-action neuroleptics in psychiatric therapeutics].

  Pellet J, Guyotat J, Marie-Cardine M, Dubor P, Favre-Tissot M, Caron F, Cottraux J. Pellet J, et al. J Med Lyon. 1972 Apr 20;53(227):591-8. J Med Lyon. 1972. PMID: 4404295 French. No abstract available.
• Review of clinical trials with pipotiazine, pipotiazine undecylenate and pipotiazine palmitate.

  Brown-Thomsen J. Brown-Thomsen J. Acta Psychiatr Scand Suppl. 1973;241:119-38. doi: 10.1111/j.1600-0447.1973.tb07049.x. Acta Psychiatr Scand Suppl. 1973. PMID: 4151807 Review. No abstract available.
• [Indications for the use of neuleptil. Review of the literature and clinical contribution].

  Catalano A, Del Pistoia L, De Risio C, Ridolo P. Catalano A, et al. Riv Sper Freniatr Med Leg Alien Ment. 1967;91:Suppl 5:1307+. Riv Sper Freniatr Med Leg Alien Ment. 1967. PMID: 4388059 Review. Italian. No abstract available.